Brexpiprazole is a medicine used to treat schizophrenia, to help antidepressants work better for depression, and to calm agitation in people with Alzheimer's dementia. It's taken as a pill once a day. It works by balancing brain chemicals called dopamine and serotonin.
Every report comes from a Lived member, sent anonymously.
Have you tried Rexulti (Brexpiprazole) for Depression?
Brexpiprazole, sold in the US as Rexulti, is a prescription medicine from the group called atypical antipsychotics. Despite that name, it has three quite different approved uses. In adults with major depression, it is added to an antidepressant when the antidepressant alone has not helped enough. It does not replace the antidepressant. It is also approved to treat schizophrenia, a long-term condition that affects how a person thinks, perceives and feels, in adults and in teenagers aged 13 and older. And it treats agitation in people with dementia caused by Alzheimer's disease: behaviors such as pacing, restlessness, shouting or aggression that can be distressing for the person and hard on caregivers. Brexpiprazole is not approved for dementia-related psychosis (losing touch with reality because of dementia) when Alzheimer's agitation is not present.
Dopamine and serotonin are chemical messengers that help brain cells communicate, and both are involved in mood, motivation, perception and arousal. Brexpiprazole attaches to some of their receptors, the docking sites that receive these signals. At one type of dopamine receptor and one type of serotonin receptor, it acts as a partial agonist: it switches the receptor on, but only part of the way. Where dopamine signaling is too strong, as is thought to happen in psychosis, this tones it down; where signaling is weak, it can provide some activity. At a second type of serotonin receptor it blocks the signal instead. Exactly how this combination relieves depression, psychosis or agitation is not known, and the receptor picture is a partial explanation rather than a full account of why it helps.
Brexpiprazole is a tablet taken once a day, with or without food. The prescriber starts with a low dose and raises it step by step over one to several weeks, and the schedule depends on what it is treating. Following that schedule matters, because side effects such as dizziness and restlessness are more likely when the dose goes up. Doses for depression and Alzheimer's agitation are usually lower than those for schizophrenia. For Alzheimer's agitation it is taken every day, not as an as-needed medicine on difficult days. Lower maximum doses apply to people with moderate or severe liver disease or reduced kidney function, and to people whose bodies break the drug down slowly for genetic reasons. Because several other medicines can raise or lower brexpiprazole levels, the dose may also change when another medicine is started or stopped.
The most common side effects in adults are weight gain, sleepiness, dizziness, cold-like symptoms and akathisia, an uncomfortable inner restlessness and urge to keep moving. In the depression studies, akathisia became more frequent as the dose increased. Teenagers taking it for schizophrenia more often notice stiffness, shaking or slowed movement. Dizziness or lightheadedness on standing is most likely early in treatment or after a dose increase, and in older adults it can lead to falls. Like other antipsychotics, brexpiprazole can raise blood sugar and blood fats and can cause gradual weight gain, which is why these are monitored. It can cause tardive dyskinesia, repetitive movements you cannot control, often of the face, tongue or lips; these may not go away, so new movements should be reported to the prescriber. Some people develop intense urges to gamble, shop, binge eat or have sex, and may not recognize them as a change, so family members' observations are useful. A rare but dangerous reaction called neuroleptic malignant syndrome causes high fever, stiff muscles, confusion, a racing or irregular pulse, changes in blood pressure and heavy sweating. These signs need emergency care right away.
Brexpiprazole carries the US Food and Drug Administration's most serious warning, a boxed warning, on two points. First, older people with dementia-related psychosis who take antipsychotic medicines have a higher risk of death, mostly from heart problems or infections such as pneumonia, and a higher risk of stroke. For a person with Alzheimer's agitation, that risk should be weighed openly with the care team against the distress the agitation causes. Second, antidepressant treatment can increase suicidal thoughts and behaviors in children, teenagers and young adults up to age 24, especially in the first months or after a dose change. Any new or sudden change in mood or behavior, or thoughts of suicide, should be reported to the prescriber right away. The liver breaks brexpiprazole down using two enzymes. Medicines that block them, such as the antifungal itraconazole, some antibiotics, and the antidepressants fluoxetine or paroxetine, can raise its level, while medicines that speed them up, such as the seizure medicine carbamazepine or the antibiotic rifampin, can lower it. The prescriber may change the dose, so tell them and the pharmacist about every prescription, over-the-counter medicine and supplement, and about any change. Alcohol and other sedating medicines can add to drowsiness. Do not drive or operate machinery until you know how it affects you. Avoid overheating and dehydration, since the drug can make it harder for the body to cool down. Taking it late in pregnancy can cause movement or withdrawal symptoms in the newborn, so anyone pregnant or planning pregnancy should discuss it with their prescriber.
When it is added for depression, improvement is usually judged over about six weeks. In the studies that led to approval, people whose depression had not improved enough on an antidepressant did somewhat better with brexpiprazole added than with a placebo added, but the extra benefit was modest on average and varies from person to person. For Alzheimer's agitation, the studies measured change over 12 weeks, so a fair trial takes time, and caregiver reports help judge whether behaviors are actually easing. Treatment involves regular check-ins. Expect weight and blood sugar to be checked before or soon after starting, and periodically afterward, with blood fats checked as well. The prescriber should ask about restlessness, movements and unusual urges, and should periodically reassess whether the medicine is still needed and at the lowest effective dose. Schizophrenia is often treated long term, while the need for add-on treatment in depression or for agitation is reviewed over time. Dose changes and stopping should be planned with the prescriber.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Rexulti (Brexpiprazole), what you've noticed, or ask the community a question.